Findings

What do systematic reviews say?

46 questions · 48 findings · 5 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 12 · 25%GRADE not reported 0 · 0%Very low 12 · 25%Low 17 · 35.4%Moderate 6 · 12.5%High 1 · 2.1%

DPP‐4 inhibitors vs insulin glargine

HbA1c (%) · pre‐existing and new‐onset diabetes in kidney transplant recipients

1 finding from 1 review

Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 45 participants
Very low

DPP‐4 inhibitors vs insulin glargine

FBG (mmol/L) · pre‐existing and new‐onset diabetes in kidney transplant recipients

1 finding from 1 review

Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 45 participants
Very low

DPP‐4 inhibitors vs insulin glargine

Kidney function markers · pre‐existing and new‐onset diabetes in kidney transplant recipients

The review found no eligible studies for this question.

1 finding from 1 review

Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

DPP‐4 inhibitors vs insulin glargine

Death (any cause) · pre‐existing and new‐onset diabetes in kidney transplant recipients

The review found no eligible studies for this question.

1 finding from 1 review

Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

DPP‐4 inhibitors vs insulin glargine

Hypoglycaemia · pre‐existing and new‐onset diabetes in kidney transplant recipients

1 finding from 1 review

Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 45 participants
Very low

DPP‐4 inhibitors vs insulin glargine

Discontinuation of medication due to adverse events · pre‐existing and new‐onset diabetes in kidney transplant recipients

1 finding from 1 review

Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 45 participants
Very low